Carvedilol
NDC Package 53808-0603-1

11-digit billing NDC: 53808060301

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Carvedilol is contraindicated in the following conditions:Bronchial asthma or related bronchospastic conditions. Marketed by State Of Florida Doh Central Pharmacy, this product is identified by NDC 53808-0603 and is authorized under FDA application ANDA078251.

Identification & Billing

NDC Package Code
53808-0603-1
Package Description
30 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
53808060301
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Carvedilol
Dosage Form
-
Usage Information
Carvedilol is contraindicated in the following conditions:Bronchial asthma or related bronchospastic conditions. Deaths from status asthmaticus have been reported following single doses of carvedilol.Second or third degree AV blockSick sinus syndromeSevere bradycardia (unless a permanent pacemaker is in place)Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy. Such patients should first be weaned from intravenous therapy before initiating carvedilol. Patients with severe hepatic impairment Patients with a history of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to carvedilol, any of the components of carvedilol tablets.

Regulatory & Marketing

Labeler Name
State Of Florida Doh Central Pharmacy
FDA Application #
ANDA078251
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-01-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53808-0603-1 identifies a specific commercial package of 30 tablet in 1 blister pack of Carvedilol, labeled by State Of Florida Doh Central Pharmacy. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by State Of Florida Doh Central Pharmacy on July 01, 2009. The current certification is valid through December 31, 2017.

How is this State Of Florida Doh Central Pharmacy product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53808060301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53808-0603-1
11-Digit CMS (5-4-2)
53808-0603-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.